Infant Formula Safety Modernization Act of 2026

Stricter infant formula safety rules

If enacted, the FDA would have 90 days to issue final rules updating infant formula manufacturing and product testing. The rules would require testing of both factories and finished formula for listed pathogens, including Clostridium botulinum. The rules would require environmental testing in defined Zone 2 and Zone 3 areas and set inspection standards the same for all formula, no matter where it is made. Infant formula makers would have to send the FDA written notice within one business day of any positive test for listed pathogens and keep records for inspections. The FDA would have to notify four congressional committees in writing within one business day after a positive finished-product test or after an 'official action indicated' inspection classification.